INS and obesity due to melanocortin 4 receptor deficiency: Some beneficial results of TRE have been described at the metabolic level in people with obesity or overweight, including an increase in lipid oxidation [7], a decrease in plasma glucose levels [8], and an improvement of insulin sensitivity [9].